Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.

DNA recombination involves combining genes from different organisms into one DNA molecule, allowing human genes to be ... the frontier of the emerging biotech industry, as the one place in the ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...

Following the success of Humulin, recombinant DNA technology was quickly adopted to replace older methods of producing medical products from human growth hormone to vaccines. Although scientists have ...

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.

Notably, at this meeting, there were people in the room from the biotech industry ... human editing flowed. On Wednesday, those in attendance made it clear that altering the DNA of embryos ...

The study, published in Biotechnology Journal, used genetic engineering techniques to integrate a human DNA segment that produces ... our well-established dairy industry,” Wheeler said.

Researchers work in a mobile Fire-Eye laboratory in Beijing in June 2020. The labs can identify coronavirus infections, as well as decipher and analyze human DNA. (Fu Tian/China News Service/Getty ...

The International Space Station (ISS) has been a testbed for sustaining human life in ... funding models support biotech-space partnerships across academia and industry, allowing research to ...